In a primary for this weblog, I’m updating a submit from ten years in the past! Perhaps I ought to change the title and take away the phrase “failure”? I’m wondering how lots of the authentic 15 commentators are nonetheless visiting this website?

Update: March 9, 2024

Stemson Therapeutics (US) and Aderans (Japan) new licensing settlement. Screenshot from Nikkei Asia.

Stemson Therapeutics and Aderans Announce Licensing Deal

Earlier right this moment, Stemson Therapeutics (US) and Aderans (Japan), the mum or dad firm of Bosley® and HAIRCLUB®, announced a partnership agreement (licensing deal).

This association secures Stemson the exclusive global rights to analysis, develop and commercialize hair regeneration therapeutic merchandise primarily based on Aderans’ proprietary hair regeneration cell remedy expertise. Note that Aderans and and Intercytex represented the one two main hopes for a hair loss treatment all through the Nineties and early 2000s. And then firms each folded and made me initially write this submit a decade in the past.

Stemson right this moment possible represents the primary hope for a hair loss treatment, though there are a variety of different contenders in China, Japan, South Korea and the US. At least with regards to a lot improved hair loss therapies

Getting again to Stemson, the corporate is growing a proprietary cell remedy for reversing hair loss that’s primarily based on induced pluripotent stem cells (iPSC). Per the press launch, it now:

“Gains a complementary technology through this agreement. Stemson will resume Aderans’ Phase 2 clinical stage cell therapy hair regeneration program, integrate the technology into its existing hair loss cell therapy development pipeline, and provide multiple products for patients experiencing hair loss.”

What an amazing growth. Aderans is again from the lifeless. It additionally looks as if a backup plan for Stemson in case its essential iPSC expertise doesn’t pan out. Moreover, maybe Stemson may now begin Phase 2 trials for Aderan’s hair regeneration expertise. Especially in Japan, with extra favorable regenerative medication sector laws.

Quote from Stemson CEO Geoff Hamilton:

“The synergies between the Aderans technology and Stemson’s in-house technology will help us accelerate timelines across our programs.”

Quote from Aderans CEO Yoshihiro Tsumura:

“We look forward to working with the Stemson team to enable their development efforts and to support the commercialization through our global network of clinics serving hair loss patients.”

Quote from the evergreen Ken Washenik (Chief Medical Officer of Bosley Medical and former CEO of Aderans Research Institute):

“Our pioneering work at the Aderans Research Institute to develop the first ever cell therapy solution for hair loss showed tremendous promise in clinical trials to treat early stage Androgenetic Alopecia in men and women. We believe Stemson, with their advanced expertise in hair follicle cell and tissue engineering, is ideally positioned to successfully complete development and commercialization of this exciting hair regeneration solution.”

November 25, 2014

Aderans and Intercytex: Hair Multiplication Failure

All the good information this 12 months associated to hair loss analysis, trials and potential cures has made folks very optimistic. However, lots of hair loss victims have gotten excessively passionate a couple of choose few firms (particularly Histogen and Replicel) or concerning the outcomes from a choose few medical trials.

I due to this fact determined to jot down this submit as a warning from previous experiences of placing an excessive amount of religion into anyone or two entities. Something so simple as lack of adequate funding regardless of profitable stage 2 medical trials could cause an organization to cease pursuing extremely promising merchandise.

In the early-to-late 2000s, two firms named Aderans (Japan) and Intercytex (UK) prompted great pleasure in all the net hair loss boards. Both have been concerned in groundbreaking analysis associated to hair cloning and hair multiplication.

Moreover, Aderans’ analysis was led by the famend Dr. Ken Washenik by way of the Aderans Research Institute. He made quite a few shows about their expertise at numerous conferences. Below are two of these:

However, in 2013, Aderans determined to liquidate its analysis institute. Spencer Kobren had a section about this on his often weekly Bald Truth present. Also starring legendary hair loss sufferer and caller “Joe from Staten Island”.

Intercytex deserted its dermal papilla cell culturing work in 2010 as a consequence of monetary difficulties, regardless of positive results from phase 1 trials. According to the corporate’s web site, in 2010 the Intercytex identify and ICX-RHY have been bought by personal traders and relaunched as Intercytex Ltd. ICX-RHY is a pores and skin restore product.

As of 2014, Aderans’ research is targeted on wigs and hair alternative. They bought US-based hair restoration market main firms Hair Club in 2013 and Bosley in 2001. Intercytex as an organization is not in existence.



Source by [author_name]

Leave a comment

Your email address will not be published. Required fields are marked *